Chris Broderick

Chief Executive Officer @Merakris Therapeutics, Inc.

Support operations and strategic planning around market access, clinical trials, intellectual property development, commercial scaling, and federal reporting obligations Lead clinical and regulatory operations including eCTD technical writing of commercial IND package that resulted in FDA clearance and IRB approved Phase II clinical study for subcutaneous biologic Support various research projects including patent-pending potency assay program, downstream bioprocessing, and grant collaboration projects Manage financial budgets, investor relations, and support manufacturing cost accounting within Enterprise Resource Planning software